Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms

T Parasassi,R Brunelli,L Bracci-Laudiero,G Greco,A C Gustafsson,E K Krasnowska,J Lundeberg,T Lundeberg,E Pittaluga,M C Romano,A Serafino
DOI: https://doi.org/10.1038/sj.cdd.4401663
IF: 12.067
2005-05-27
Cell Death and Differentiation
Abstract:We examined the morphological, biochemical and molecular outcome of a nonspecific sulfhydryl reduction in cells, obtained by supplementation of N-acetyl-L-cysteine (NAC) in a 0.1–10?mM concentration range. In human normal primary keratinocytes and in colon and ovary carcinoma cells we obtained evidences for: (i) a dose-dependent inhibition of proliferation without toxicity or apoptosis; (ii) a transition from a proliferative mesenchymal morphology to cell-specific differentiated structures; (iii) a noticeable increase in cell–cell and cell–substratum junctions; (iv) a relocation of the oncogenic β-catenin at the cell–cell junctions; (v) inhibition of microtubules aggregation; (vi) upregulation of differentiation-related genes including p53, heat shock protein 27 gene, N-myc downstream-regulated gene 1, E-cadherin, and downregulation of cyclooxygenase-2; (vii) inhibition of c-Src tyrosine kinase. In conclusion, a thiol reduction devoid of toxicity as that operated by NAC apparently leads to terminal differentiation of normal and cancer cells through a pleiade of converging mechanisms, many of which are targets of the recently developed differentiation therapy.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?